serotonin reuptake inhibitors use (including Paxil) during pregnancy increases risk of preterm birth
San Diego, CA (PRWEB) August 30, 2012
The media spotlight is often a double-edged sword. No one knows this better than people who filed a Paxil Lawsuit. And yet, gossip and rumor-mongering aside, the real story here is being overlooked according to Sean Burke of AttorneyOne.
A new study, published online on May 23rd 2012 in the journal Epidemiology, reveals that serotonin reuptake inhibitors use (including Paxil) during pregnancy increases risk of preterm birth. Paxil is an antidepressant drug belonging to a group called selective serotonin reuptake inhibitors (SSRIs). The study was conducted among 2793 pregnant women and was led by Kimberly Yonkers, MD, a professor of psychiatry and of obstetrics, gynecology and reproductive sciences at Yale School of Public Health.
In October 2010, a Philadelphia jury (case no. 070201813 - Court of Common Pleas, Philadelphia County, Pennsylvania) ordered GlaxoSmithKline to pay $2.5 million to the family of a 3-year-old boy, Lyam Kilker, who was born with heart defects. In July 2010, Bloomberg News reported that a $2.4 billion set aside that GlaxoSmithKline announced earlier to settle outstanding liabilities included the settlement of Paxil birth defect lawsuits brought by parents who said that use of Paxil during pregnancy caused persistent pulmonary hypertension in newborns (PPHN) or other problems for their babies.
AttorneyOne.com, a recognized authority on law, can provide helpful advice and simple solutions including how to get in contact with legal counsel so that, in case of severe adverse events from Paxil, someone can easily and inexpensively deal with it. As Mr. Burke, director of Media Relations for AttorneyOne.com, added, “What all this information really illustrates is that threat from Paxil remains. For that reason, our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”
As Bloomberg reported on July 5th, 2012, GlaxoSmithKline pleaded guilty to illegal promotion of the drugs Paxil and Weelbutrin and failure to provide clinical data on Avandia as part of a $3 billion settlement with the U.S. (case no. 12-10206, U.S. District Court, District of Massachusetts).
AttorneyOne.com has further information on Paxil lawsuits including how to get in contact with legal counsel.
Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2012/8/prweb9815610.htm.